These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10481119)

  • 1. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
    Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
    J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
    Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
    Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
    Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
    Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
    Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
    Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
    Borre M; Stausbol-Gron B; Overgaard J
    J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas.
    Ohshio G; Suwa H; Imamura T; Yamaki K; Tanaka T; Hashimoto Y; Imamura M
    Scand J Gastroenterol; 1998 May; 33(5):535-9. PubMed ID: 9648995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.
    Sinicrope FA; Evans DB; Leach SD; Cleary KR; Fenoglio CJ; Lee JJ; Abbruzzese JL
    Clin Cancer Res; 1996 Dec; 2(12):2015-22. PubMed ID: 9816161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
    Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
    Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
    Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
    J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Eur J Surg Oncol; 2003 Oct; 29(8):654-7. PubMed ID: 14511612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
    Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer.
    Laudanski J; Niklinska W; Burzykowski T; Chyczewski L; Niklinski J
    Eur Respir J; 2001 Apr; 17(4):660-6. PubMed ID: 11401061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Seidal T
    Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.